American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

(2021) Brian J Boyarsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

(2021) Liana Fraenkel et al.   Arthritis & Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Case of adult large vessel vasculitis after SARS-CoV-2 infection

(2020) Ryohei Oda et al.   ANNALS OF THE RHEUMATIC DISEASES

COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases

(2020) D. Baker et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study

(2020) Amit Bar-Or et al.   NEUROLOGY

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

(2020) Roch Houot et al.   EUROPEAN JOURNAL OF CANCER

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

(2020) Ugur Sahin et al.   NATURE

High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

(2020) Laura Doornekamp et al.   Vaccines

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

(2020) Bina Choi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

(2020) René Cordtz et al.   RHEUMATOLOGY

COVID‐19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi‐Center Comparative Cohort Study

(2020) Kristin M. D’Silva et al.   Arthritis & Rheumatology

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry

(2020) Milena A. Gianfrancesco et al.   Arthritis & Rheumatology

Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial

(2019) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2019) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab

(2019) Victoria Furer et al.   VACCINE

Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials

(2019) Jin Kyun Park et al.   CLINICAL RHEUMATOLOGY

A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis

(2018) Sujith Subesinghe et al.   JOURNAL OF RHEUMATOLOGY

Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American Co

(2018) Désirée van der Heijde et al.   Arthritis & Rheumatology

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

(2018) Jasvinder A. Singh et al.   Arthritis & Rheumatology

Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases

(2017) Huifeng Yun et al.   JOURNAL OF RHEUMATOLOGY

Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine

(2017) J Nagel et al.   LUPUS

Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine

(2017) Meliha C. Kapetanovic et al.   VACCINE

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

(2016) Rieke Alten et al.   BMC MUSCULOSKELETAL DISORDERS

Effect of antipyretic analgesics on immune responses to vaccination

(2016) Ezzeldin Saleh et al.   Human Vaccines & Immunotherapeutics

Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination

(2016) Huifeng Yun et al.   Arthritis & Rheumatology

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

(2015) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination

(2015) A. Egli et al.   JOURNAL OF INFECTIOUS DISEASES

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

(2015) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients

(2015) Kiyoshi Migita et al.   ARTHRITIS RESEARCH & THERAPY

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus

(2015) Kiyoshi Migita et al.   ARTHRITIS RESEARCH & THERAPY

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

(2014) Clifton O Bingham et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

(2014) J. Westra et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2014) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

(2014) Meliha C Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients

(2013) A. Baluch et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

(2013) Shunsuke Mori et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

(2013) I. Nazi et al.   BLOOD

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2013) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab

(2013) Tomomi Tsuru et al.   Modern Rheumatology

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study

(2012) Chi Chiu Mok et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

(2012) Shunsuke Mori et al.   ANNALS OF THE RHEUMATIC DISEASES

Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study

(2012) Aatke van der Maas et al.   ANNALS OF THE RHEUMATIC DISEASES

Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine

(2012) Claire-Anne Siegrist et al.   ANTIVIRAL THERAPY

Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study

(2012) William A Blumentals et al.   BMC MUSCULOSKELETAL DISORDERS

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

(2012) Lindsey R. Baden et al.   JOURNAL OF INFECTIOUS DISEASES

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

(2012) Ana C. Ribeiro et al.   ARTHRITIS CARE & RESEARCH

Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors

(2011) Meliha Crnkic Kapetanovic et al.   ARTHRITIS AND RHEUMATISM

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

(2011) Cem Gabay et al.   ARTHRITIS AND RHEUMATISM

GRADE guidelines: 8. Rating the quality of evidence—indirectness

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease

(2011) N. E. AIKAWA et al.   JOURNAL OF RHEUMATOLOGY

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study

(2011) S. Adler et al.   RHEUMATOLOGY

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

(2011) Ori Elkayam et al.   ARTHRITIS CARE & RESEARCH

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

(2010) S. van Assen et al.   AUTOIMMUNITY REVIEWS

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment

(2010) Maria Rehnberg et al.   ARTHRITIS RESEARCH & THERAPY

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Performance of the tuberculin skin test and interferon-γ release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population

(2009) Eun Young Kim et al.   BMC INFECTIOUS DISEASES

Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving either Azathioprine or Mycophenolate: A Controlled Trial

(2008) Maryam Keshtkar-Jahromi et al.   AMERICAN JOURNAL OF NEPHROLOGY